Wird geladen...
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
BACKGROUND: The use of anthracyclines is limited by the occurrence of cardiotoxicity. In an effort to prevent this cardiotoxicity, different anthracycline derivates have been studied. OBJECTIVES: To determine the occurrence of cardiotoxicity with the use of different anthracycline derivates in cance...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2010
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457588/ https://ncbi.nlm.nih.gov/pubmed/20464735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005006.pub4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|